These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 28815274)

  • 21. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
    Zhang T; Watson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a clinically relevant liquid chromatography tandem mass spectrometry assay for 13 drugs of abuse in urine, designed to meet the needs of the service users.
    Duxbury K; Romagnoli C; Anderson M; Watts R; Waite G
    Ann Clin Biochem; 2010 Sep; 47(Pt 5):415-22. PubMed ID: 20595401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical aspects of urine profiling for the selection of potential biomarkers using UPLC-TOF-MS.
    Mattarucchi E; Guillou C
    Biomed Chromatogr; 2012 Apr; 26(4):512-7. PubMed ID: 22116777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adulteration of urine drug testing--an exaggerated cause of concern].
    Beck O; Bohlin M; Bragd F; Bragd J; Greitz O
    Lakartidningen; 2000 Feb; 97(7):703-6. PubMed ID: 10740378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs of abuse screening in urine as part of a metabolite-based LC-MSn screening concept.
    Wissenbach DK; Meyer MR; Remane D; Philipp AA; Weber AA; Maurer HH
    Anal Bioanal Chem; 2011 Jul; 400(10):3481-9. PubMed ID: 21533799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a universal metabolome-standard method for long-term LC-MS metabolome profiling and its application for bladder cancer urine-metabolite-biomarker discovery.
    Peng J; Chen YT; Chen CL; Li L
    Anal Chem; 2014 Jul; 86(13):6540-7. PubMed ID: 24877652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Untargeted metabolomics in doping control: detection of new markers of testosterone misuse by ultrahigh performance liquid chromatography coupled to high-resolution mass spectrometry.
    Raro M; Ibáñez M; Gil R; Fabregat A; Tudela E; Deventer K; Ventura R; Segura J; Marcos J; Kotronoulas A; Joglar J; Farré M; Yang S; Xing Y; Van Eenoo P; Pitarch E; Hernández F; Sancho JV; Pozo ÓJ
    Anal Chem; 2015 Aug; 87(16):8373-80. PubMed ID: 26200763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneous LC-MS/MS determination of JWH-210, RCS-4, ∆(9)-tetrahydrocannabinol, and their main metabolites in pig and human serum, whole blood, and urine for comparing pharmacokinetic data.
    Schaefer N; Kettner M; Laschke MW; Schlote J; Peters B; Bregel D; Menger MD; Maurer HH; Ewald AH; Schmidt PH
    Anal Bioanal Chem; 2015 May; 407(13):3775-86. PubMed ID: 25772567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Nitro-6-monoacetylmorphine: potential marker for monitoring the presence of 6-monoacetylmorphine in urine adulterated with potassium nitrite.
    Luong S; Shimmon R; Hook J; Fu S
    Anal Bioanal Chem; 2012 Jun; 403(7):2057-63. PubMed ID: 22526670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a pre-analysis osmolality normalisation method to correct for variable urine concentrations and for improved metabolomic analyses.
    Chetwynd AJ; Abdul-Sada A; Holt SG; Hill EM
    J Chromatogr A; 2016 Jan; 1431():103-110. PubMed ID: 26755417
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of biochemical assays and optimization of LC-MS-MS analysis for the detection of synthetic urine.
    Franke L; Fuczik C; Hubig M; Peters FT; Wissenbach DK
    J Anal Toxicol; 2024 Jan; 48(1):37-43. PubMed ID: 37933588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid chromatography-quadrupole-time-of-flight mass spectrometry screening procedure for urine samples in forensic casework compared to gas chromatography-mass spectrometry.
    Fels H; Dame T; Sachs H; Musshoff F
    Drug Test Anal; 2017 May; 9(5):824-830. PubMed ID: 27373549
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic re-evaluation of the long-used standard protocol of urease-dependent metabolome sample preparation.
    Kim J; Ahn JK; Cheong YE; Lee SJ; Cha HS; Kim KH
    PLoS One; 2020; 15(3):e0230072. PubMed ID: 32182259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mass spectrometric identification and characterization of a new long-term metabolite of metandienone in human urine.
    Schänzer W; Geyer H; Fusshöller G; Halatcheva N; Kohler M; Parr MK; Guddat S; Thomas A; Thevis M
    Rapid Commun Mass Spectrom; 2006; 20(15):2252-8. PubMed ID: 16804957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of chemical isotope labeling liquid chromatography mass spectrometry for silkworm hemolymph metabolomics.
    Shen W; Han W; Li Y; Meng Z; Cai L; Li L
    Anal Chim Acta; 2016 Oct; 942():1-11. PubMed ID: 27720112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid comparison of metabolites in humans and rats of different sexes using untargeted UPLC-TOFMS and an in-house software platform.
    Liang Q; Xu W; Hong Q; Xiao C; Yang L; Ma Z; Wang Y; Tan H; Tang X; Gao Y
    Eur J Mass Spectrom (Chichester); 2015; 21(6):801-21. PubMed ID: 26764310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of spot tests with AdultaCheck 6 and Intect 7 urine test strips for detecting the presence of adulterants in urine specimens.
    Dasgupta A; Chughtai O; Hannah C; Davis B; Wells A
    Clin Chim Acta; 2004 Oct; 348(1-2):19-25. PubMed ID: 15369731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovery of common urinary biomarkers for hepatotoxicity induced by carbon tetrachloride, acetaminophen and methotrexate by mass spectrometry-based metabolomics.
    Kumar BS; Chung BC; Kwon OS; Jung BH
    J Appl Toxicol; 2012 Jul; 32(7):505-20. PubMed ID: 22131085
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.